Cargando…
COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic
BACKGROUND: Coronavirus disease 2019 (COVID-19) represents an important infectious complication associated with high mortality rates in patients with hematologic diseases. There have not been published any epidemiologic studies from Czech Republic so far. PATIENTS AND METHODS: This study is the firs...
Autores principales: | Čerňan, Martin, Szotkowski, Tomáš, Obr, Aleš, Látal, Vojtěch, Hluší, Antonín, Krhovská, Petra, Klementová, Olga, Kolář, Milan, Sauer, Pavel, Faber, Edgar, Fürst, Tomáš, Papajík, Tomáš |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165561/ https://www.ncbi.nlm.nih.gov/pubmed/34083176 http://dx.doi.org/10.1016/j.clml.2021.04.016 |
Ejemplares similares
-
Breakthrough COVID-19 in Vaccinated Patients with Haematologic Malignancies—The First Single-Centre Experience from the Czech Republic
por: Čerňan, Martin, et al.
Publicado: (2022) -
PB1883: IMPLANTATION AND LONG-TERM USE OF PERIPHERALLY-INSERTED CENTRAL CATHETER ARE SAFE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKAEMIA
por: Szotkowski, Tomáš, et al.
Publicado: (2023) -
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
por: Obr, Ales, et al.
Publicado: (2022) -
Refractory immune thrombocytopenia. Successful treatment with repeated cyclosporine A: two case reports
por: Hlusi, Antonin, et al.
Publicado: (2015) -
Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for FLT3-mutated acute myeloid leukemia patients – Czech center experience
por: Weinbergerová, Barbora, et al.
Publicado: (2023)